Joe Y Chang: Intensity-modulated proton vs photon therapy with concurrent chemo in medical inoperable stage III NSCLC

Joe Y Chang, Professor and Director, Stereotactic Ablative Radiotherapy Program, MD Anderson Cancer Center, shared a post on X:

“MD Anderson finished all enrollment of phase II randomized study comparing intensity-modulated proton vs photon therapy with concurrent chemo in medical inoperable stage III NSCLC.

I am lucky enough to enroll the last pt and received a nice bottle of wine from Zhongxing Liao.”

Source: Joe Y Chang/X